These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18720909)

  • 1. Lysosomal storage diseases.
    Manwaring LP; Jamerson PA; Slaugh R
    RN; 2008 Jul; 71(7):33-7; quiz 38. PubMed ID: 18720909
    [No Abstract]   [Full Text] [Related]  

  • 2. Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
    Lim-Melia ER; Kronn DF
    Pediatr Ann; 2009 Aug; 38(8):448-55. PubMed ID: 19725195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enzyme replacement therapy of lysosomal storage diseases].
    Germain DP; Boucly C; Carlier RY; Caudron E; Charlier P; Colas F; Jabbour F; Martinez V; Mokhtari S; Orlikowski D; Pellegrini N; Perronne C; Prigent H; Rubinsztajn R; Benistan K
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S279-91. PubMed ID: 21211680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening patients referred to a metabolic clinic for lysosomal storage disorders.
    Fuller M; Tucker JN; Lang DL; Dean CJ; Fietz MJ; Meikle PJ; Hopwood JJ
    J Med Genet; 2011 Jun; 48(6):422-5. PubMed ID: 21415080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme reconstitution/replacement therapy for lysosomal storage diseases.
    Burrow TA; Hopkin RJ; Leslie ND; Tinkle BT; Grabowski GA
    Curr Opin Pediatr; 2007 Dec; 19(6):628-35. PubMed ID: 18025928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme Replacement Therapy for Lysosomal Storage Diseases.
    Kleppin S
    J Infus Nurs; 2020; 43(5):243-245. PubMed ID: 32881810
    [No Abstract]   [Full Text] [Related]  

  • 7. Fabry disease: a treatable lysosomal storage disorder.
    Phadke SR; Mandal K; Girisha KM
    Natl Med J India; 2009; 22(1):20-2. PubMed ID: 19761154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overview of enzyme replacement therapy in mucopolysaccharidosis].
    Fouilhoux A; Guffon N
    Presse Med; 2007 Mar; 36 Spec No 1():1S96-9. PubMed ID: 17546776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of hereditary neurological disorders during childhood].
    Ohno K; Ohashi T
    No To Hattatsu; 2007 Mar; 39(2):132-5. PubMed ID: 17370634
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of frequencies of alleles, associated with the pseudodeficiency of lysosomal hydrolases, in population of Ukraine.
    Olkhovych NV; Gorovenko NG
    Ukr Biochem J; 2016; 88(5):96-106. PubMed ID: 29235819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses.
    Muenzer J
    Mol Genet Metab; 2014 Feb; 111(2):63-72. PubMed ID: 24388732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic challenges and new therapies for rare lysosomal storage diseases.
    Hesselgrave B
    Case Manager; 2003; 14(6):48-52. PubMed ID: 14618149
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical practice guideline for the management of Hunter syndrome. Hunter España working group].
    Guillén-Navarro E; Blasco AJ; Gutierrez-Solana LG; Couce ML; Cancho-Candela R; Lázaro P;
    Med Clin (Barc); 2013 Nov; 141(10):453.e1-13. PubMed ID: 24060500
    [No Abstract]   [Full Text] [Related]  

  • 14. Fabry disease with special reference to neurological manifestations.
    Banerjee TK
    Eur Rev Med Pharmacol Sci; 2004; 8(6):275-81. PubMed ID: 15745387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of lysosomal storage diseases: update and perspectives].
    Lara-Aguilar RA; Juárez-Vázquez CI; Medina-Lozano C
    Rev Invest Clin; 2011; 63(6):651-8. PubMed ID: 23650678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry disease (cardiac lysosomal storage disease) associated with heart failure].
    Takenaka T; Tei C
    Nihon Rinsho; 2007 May; 65 Suppl 5():460-4. PubMed ID: 17571419
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
    Mignani R; Cagnoli L
    J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of lysosomal diseases amongst metabolic diseases].
    Saudubray JM
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S11-3. PubMed ID: 16644394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of children with Hunter syndrome - a case study.
    Little C; Gould R; Hendriksz C
    Br J Nurs; 2009 Mar 12-25; 18(5):321-2. PubMed ID: 19273994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Shachar T; Lo Bianco C; Recchia A; Wiessner C; Raas-Rothschild A; Futerman AH
    Mov Disord; 2011 Aug; 26(9):1593-604. PubMed ID: 21618611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.